Icecure Medical Ltd (NASDAQ:ICCM) shares, rose in value on Thursday, April 16, with the stock price down by -1.32% to the previous day’s close as strong demand from buyers drove the stock to $1.12.
Actively observing the price movement in the last trading, the stock closed the session at $1.14, falling within a range of $1.1 and $1.148. The value of beta (5-year monthly) was 2.311. Referring to stock’s 52-week performance, its high was $1.66, and the low was $0.48. On the whole, ICCM has fluctuated by -23.99% over the past month.
With the market capitalization of Icecure Medical Ltd currently standing at about $63.64 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-26.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 6.36M, with a low estimate of 750k and a high estimate of 750k. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 750k.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ICCM’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of ICCM currently trading nearly -3.19% and -12.74% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.72, while the 7-day volatility ratio is showing 6.18% which for the 30-day chart, stands at 8.49%. Furthermore, Icecure Medical Ltd (ICCM)’s average true range (ATR) is 0.09.
A comparison of Icecure Medical Ltd (ICCM) with its peers suggests the former has fared considerably weaker in the market. ICCM showed an intraday change of -1.32% in last session, and over the past year, it shrunk by -13.46%%.
Data on historical trading for Icecure Medical Ltd (NASDAQ:ICCM) indicates that the trading volumes over the past 10 days have averaged 0.17 and over the past 3 months, they’ve averaged 319.14K. According to company’s latest data on outstanding shares, there are 56.57 million shares outstanding.
Nearly 48.54% of Icecure Medical Ltd’s shares belong to company insiders and institutional investors own 0.27% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.29 million shares as on 2025-03-31, resulting in a short ratio of 0.83. According to the data, the short interest in Icecure Medical Ltd (ICCM) stood at 596.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 0.6 million. The stock has risen by 2.27% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ICCM stock heading into the next quarter.
